JHS Svendgaard Laboratories share price
NSE: JHSBSE: 532771Personal ProductsSmall Cap
JHS Svendgaard Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 2006
Last close ₹8.19up ₹0.08 (0.99%)BSE ₹8.33
Share price at the NSE close on 29 Oct 2026. Previous close ₹8.11.
29 Oct: open ₹8.06, high ₹8.38, low ₹8.06
52-week range of traded prices to 29 Oct 2026
₹6.26Low, 30 Mar 2026₹13.69High, 1 Oct 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹72 Cr3,087th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −1.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.08
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 15,353
Results
Consolidated; ₹ crore.JHS Svendgaard Laboratories quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +19.4%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- –
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹30 Crdown 7.08%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing. Net profit in the glossary
- ₹1.09 CrQuarter to Mar 2026: −₹3.57 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 3.6%
Revenue by quarter
Peak revenue ₹33 Cr, quarter to Mar 2026; lowest ₹20 Cr, quarter to Sep 2024
Net profit by quarter, a loss in red
- Net profit
- Loss
Back to profit in the quarter to Jun 2026, ₹1.09 CrA loss in 5 of the 8 quarters shown
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.7 | 22.7 | 25.2 | 23.5 | 22.3 | 23.3 | 32.7 | 30.4 |
| Net profit | −10.3 | −1.8 | −7.0 | 1.1 | −0.2 | 0.8 | −3.6 | 1.1 |
| Net margin | −52.4% | −8.1% | −27.6% | 4.5% | −0.9% | 3.4% | −10.9% | 3.6% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹102 Crup 10.54%
- Net profitNet profit. Under it, net profit in the year before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹1.92 CrYear to Mar 2025: −₹20 Cr
- Net margin
- −1.9%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 7 of the 10 years shown
The years either side of a change of basis do not compare. From the year to Mar 2024, part of the business was demerged on 11 Sep 2023, and figures before the change include the part that left.
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 105 | 143what Revenue, Mar 2018, includes. This period's revenue includes excise duty of ₹2.35 crore, a tax on the goods the company makes that it collects and pays to the government. | 124 | 139 | 101 | 86 | 96 | 71 | 92 | 102 |
| Net profit | 22 | 26 | −2 | −5 | 1 | −4 | −17 | −4 | −20 | −2 |
| Net margin | 20.8% | 18.3% | −1.3% | −3.5% | 1.3% | −5.0% | −17.4% | −5.7% | −21.4% | −1.9% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Oral Care Manufacturing, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: loss, last twelve months. Dividend yield is not shown: no dividend in the years on record. Its history crosses a change of basis in the accounts in the year to Mar 2024: days before it are of the company before the change.JHS Svendgaard Laboratories PE ratio and valuation
Price to book
At or below today's level on 6% of 1,126 trading days over the last 5 years.
LowestHighest
Its median0.75Industry median5.68
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | With the demerger reinvestedReturn with the demerger reinvested. The yearly price growth with the price before the demerger multiplied by the demerger's price factor (its opening price on the ex-date over the close before it), plus the average dividend yield: the return of a holder who put the value of the shares of the company that was split off back into this share on the ex-date. | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|---|
| 1 year | −41.4% | – | – | – | 0.0% |
| 3 years | −25.0% | −23.6% | – | – | 0.0% |
| 5 years | −20.0% | −19.1% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Return a year is the share as it traded across the demerger; the next column is the same return with the demerger reinvested, empty for a window with no demerger in it. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1, 3 and 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
JHS Svendgaard Laboratories competitors and peers
Personal Care, 21 listed companies, priced on 29 Oct 2026. The table lists the 8 companies closest to JHS Svendgaard Laboratories in market cap. 3 companies in the table last traded before then: their rows are priced on their last trade.FMCG companies
JHS Svendgaard Laboratories is not on the chart: it has no P/E today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Macobs TechnologiesMACOBSTECH | 192 | 66.12 | 4.62 | – | – | 8.3% | – | 0.00% |
 H. R. Hygiene ProductsHRHYGIENE | 134 | – | – | – | – | – | – | 0.00% |
 Aakaar Medical TechnologiesAAKAAR | 101 | 15.16 | 1.84 | – | – | 12.2% | – | 0.00% |
 Thrive Future HabitatsTHRIVE | 88 | – | 1.66 | −29.8% | – | −5.3% | −6.8% | 0.00% |
 RavelcareRAVEL | 64 | 12.38 | 1.71 | – | – | 13.8% | – | 0.00% |
 Medistep HealthcareMEDISTEP | 27 | 4.45 | 0.70 | – | – | 15.8% | – | 0.00% |
 Novateor Research LaboratoriesNOVATEOR | 26 | 239.41 | 2.26 | +37.8% | +32.9% | 1.0% | – | 0.00% |
 Paramount Cosmetics (India)PARMCOS-B | 18 | 81.32 | 0.88 | −5.9% | – | 1.1% | 1.2% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.JHS Svendgaard Laboratories dividend history
| Ex-date | Type | Per share |
|---|---|---|
| 26 Dec 2011 | Dividend | ₹0.75 |
| 22 Dec 2010 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary | ₹0.50 |
| 10 Sep 2009 | Final | ₹0.25 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.JHS Svendgaard Laboratories announcements
Oct 2026
26 Oct · Board meeting
Sep 2026
26 Sep · Meeting
17 Sep · General Updates
Aug 2026
11 Aug · Results
JHS Svendgaard Laboratories share price by year
Each calendar year to 2025.JHS Svendgaard Laboratories share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 9.82 | −53.5% | 23.23 | 9.59 |
| 2024 | 21.12 | −17.0% | 38.15 | 15.55 |
| 2023Demerger | 25.45 | +13.9% | 29.25 | 14.20 |
| 2022 | 22.35 | −18.7% | 31.70 | 20.10 |
| 2021 | 27.50 | +14.3% | 32.80 | 18.90 |
| 2020 | 24.05 | +58.7% | 26.60 | 6.90 |
| 2019 | 15.15 | −55.9% | 34.70 | 13.05 |
| 2018 | 34.35 | −54.2% | 74.70 | 24.05 |
| 2017 | 75.05 | +102.3% | 80.70 | 36.95 |
| 2016 | 37.10 | +44.9% | 45.15 | 19.05 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. With the demerger of 11 Sep 2023 reinvested, the change in 2023 is +20.3%.
Recent sessions
The 9 trading days to 28 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 28 Oct 2026 | 7.99 | 8.24 | 7.55 | 8.11 | 7.87 | 62,005 |
| 27 Oct 2026 | 8.35 | 8.49 | 7.81 | 7.93 | 8.21 | 77,060 |
| 26 Oct 2026 | 8.39 | 8.79 | 8.00 | 8.18 | 8.13 | 94,672 |
| 23 Oct 2026 | 8.78 | 8.78 | 8.41 | 8.41 | 8.43 | 63,248 |
| 22 Oct 2026 | 9.31 | 9.65 | 8.85 | 8.85 | 8.89 | 82,174 |
| 21 Oct 2026 | 9.84 | 9.94 | 9.00 | 9.31 | 9.35 | 81,833 |
| 19 Oct 2026 | 9.44 | 9.47 | 9.10 | 9.47 | 9.41 | 93,712 |
| 16 Oct 2026 | 8.82 | 9.10 | 8.63 | 9.02 | 8.98 | 1,47,252 |
| 15 Oct 2026 | 8.99 | 9.35 | 8.55 | 8.90 | 8.74 | 76,192 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Demerger history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 11 Sep 2023 | Demerger | 0.9465 | Part of the business became a separate company. The factor is the opening price on the ex-date divided by the previous close. The chart shows earlier prices with the demerger reinvested. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- NSE symbol
- JHS
- BSE code
- 532771
- ISIN
- INE544H01014
- Industry
- Personal Products
- Website
- www.svendgaard.com
- CIN
- L74110HP2004PLC027558
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2004
- Registered office
- Trilokpur Road Kala Amb, Nahan, Sirmour 173030, Himachal Pradesh
- Share registrar
- Beetal Financial & Computer Services Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments